All the Active Ingredient Drugs
Corticosteroid. Loteprednol Etabonate 5 mg/ml. OPHTH. SOLN: 5 ml. Shake vigorously
bef. use. Steroid respons. dis: 1-2 drops
into conjunct. sac of affect. eye/s 4 x
dly. During initial tmt. 1st wk, dose
may incr. up to 1 drop/hour if req. Do
not discont. prematurely. If signs,
sympts. fail to improve aft. 2 days,
reevaluate pt. Post-op. inflamm: 1-2
drops into conjunct. sac of operated
eye/s 4 x dly, begin. 24 hrs aft. surg.
Cont. throughout first 2 wks of postop.
per.
Tmt. steroid respons. inflamm. conds. of
palpebral and bulbar conjunct., cornea
and anter. segment globe, such as allergic
conjunctivit., acne rosacea, fic. punctate
keratit., herpes zoster keratit., irit., cyclit.,
select. infect. conjunctivitides, when
inherent hazard steroid use is an advis.
diminut. in edema and inflamm. post-op.
inflamm. follow. oc. surg.
C/I: Most viral dis. cornea and conjuntiv.
incl. epithel. herpes simples keratit.
(dendrit. keratit.), vaccin., varicella, in
mycobact. infect. of eye and fung. dis.
oc. struct; suspect. hypersens., to any of
the ingred. and to other corticoster.
Aminoglycoside, Corticosteroid. Loteprednol Etabonate 5 mg/ml, Tobramycin 3 mg/ml. OPHTH. SUSP: 5 ml. Shake vigorously
bef. use. Apply 1-2 drops into
conjunct. sac affect. eye/s every 4-6
hrs. During initial 24-48 hrs dos. may
be incr. to every 1-2 hrs. Don’t
discontinue ther. premat. Initial: Not
more than 20 ml, presript. not to be
refilled without further evaluat.
Steroid-respons. inflamm. oc. conds. when
indicat. and where fic. bact. oc. infect/risk
of bact. oc. infect. exists.
C/I: Most viral dis. of cornea and
conjunctiva, mycobacter. infect., fung.
dis. of oc. structures, hypersens.
